Supplemental table 2 from Preclinical Characterization of BET Family Bromodomain Inhibitor ABBV-075 Suggests Combination Therapeutic Strategies
Mai H. Bui,Xiaoyu Lin,Daniel H. Albert,Leiming Li,Lloyd T. Lam,Emily J. Faivre, Scott E. Warder,Xiaoli Huang,Denise Wilcox,Cherrie K. Donawho,George S. Sheppard,Le Wang,Steve Fidanze,John K. Pratt,Dachun Liu,Lisa Hasvold,Tamar Uziel,Xin Lu,Fred Kohlhapp,Guowei Fang,Steven W. Elmore,Saul H. Rosenberg,Keith F. McDaniel,Warren M. Kati,Yu Shen crossref（2023）
摘要
Anti-proliferative activity of MS417 across cancer cell lines
查看译文
AI 理解论文
溯源树
样例
